Zhouyang Wu

814 total citations
28 papers, 476 citations indexed

About

Zhouyang Wu is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Zhouyang Wu has authored 28 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Zhouyang Wu's work include Respiratory Support and Mechanisms (9 papers), Neonatal Respiratory Health Research (5 papers) and Immune Response and Inflammation (4 papers). Zhouyang Wu is often cited by papers focused on Respiratory Support and Mechanisms (9 papers), Neonatal Respiratory Health Research (5 papers) and Immune Response and Inflammation (4 papers). Zhouyang Wu collaborates with scholars based in China, India and Egypt. Zhouyang Wu's co-authors include You Shang, Shiying Yuan, Jie Gong, Hongbin Li, Shanglong Yao, Shanglong Yao, Hong Qi, Lin Chen, Chengye Yao and Sanpeng Xu and has published in prestigious journals such as Analytical Chemistry, Scientific Reports and British Journal of Pharmacology.

In The Last Decade

Zhouyang Wu

25 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhouyang Wu China 12 118 111 85 83 68 28 476
Bünyamin Börekçi Türkiye 16 104 0.9× 95 0.9× 57 0.7× 53 0.6× 118 1.7× 41 732
Christian Laplace France 8 78 0.7× 164 1.5× 44 0.5× 58 0.7× 118 1.7× 14 582
Tsuguru Hatta Japan 18 35 0.3× 143 1.3× 108 1.3× 111 1.3× 112 1.6× 56 991
Sergey Karamnov United States 8 192 1.6× 143 1.3× 308 3.6× 70 0.8× 110 1.6× 14 695
Sylvia Berman Israel 16 63 0.5× 159 1.4× 151 1.8× 70 0.8× 61 0.9× 56 676
Kazuo Irita Japan 14 106 0.9× 213 1.9× 32 0.4× 40 0.5× 158 2.3× 53 671
Joachim Schmeck Germany 14 51 0.4× 115 1.0× 67 0.8× 162 2.0× 143 2.1× 33 788
Alexandru Florin Rogobete Romania 15 63 0.5× 220 2.0× 101 1.2× 71 0.9× 114 1.7× 72 692
Patrick D. Harris United States 18 57 0.5× 93 0.8× 55 0.6× 135 1.6× 173 2.5× 52 833
Jakob Wollborn Germany 17 46 0.4× 247 2.2× 17 0.2× 71 0.9× 163 2.4× 43 743

Countries citing papers authored by Zhouyang Wu

Since Specialization
Citations

This map shows the geographic impact of Zhouyang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhouyang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhouyang Wu more than expected).

Fields of papers citing papers by Zhouyang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhouyang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhouyang Wu. The network helps show where Zhouyang Wu may publish in the future.

Co-authorship network of co-authors of Zhouyang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhouyang Wu. A scholar is included among the top collaborators of Zhouyang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhouyang Wu. Zhouyang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Hou-Fu, et al.. (2025). Enhancing immunotherapy efficacy in oral cancer through AKB-9778-mediated vascular normalization. International Immunopharmacology. 148. 114133–114133.
2.
Li, Mengyu, Yu Wang, Shiqian Huang, et al.. (2025). PTEN-mediated senescence of lung epithelial cells drives ventilator-induced pulmonary fibrosis. Theranostics. 15(16). 8360–8376.
3.
Li, Wenwen, Zi‐Li Yu, Zhouyang Wu, Jun Jia, & Gang Chen. (2024). Advances of extracellular vesicles in oral diseases: Summary of research progress, clinical implications and future directions. 1(1). 100004–100004.
4.
Yu, Zi‐Li, Zhouyang Wu, Xuan Wang, et al.. (2024). Predictive Analysis in Oral Cancer Immunotherapy: Profiling Dual PD-L1-Positive Extracellular Vesicle Subtypes with Step-Wedge Microfluidic Chips. Analytical Chemistry. 96(37). 14980–14988. 8 indexed citations
5.
Li, Qien, Jingyi Xu, Xin Hu, et al.. (2023). The protective effects and mechanism of Ruyi Zhenbao Pill, a Tibetan medicinal compound, in a rat model of osteoarthritis. Journal of Ethnopharmacology. 308. 116255–116255. 6 indexed citations
6.
Yang, Kai, et al.. (2023). Network meta-analysis of comparative efficacy and safety of intubation devices in children. Scientific Reports. 13(1). 18626–18626. 1 indexed citations
7.
9.
Huang, Shiqian, Shuai Zhao, Huilin Luo, et al.. (2021). The role of extracorporeal membrane oxygenation in critically ill patients with COVID-19: a narrative review. BMC Pulmonary Medicine. 21(1). 116–116. 13 indexed citations
10.
Wu, Zhouyang, et al.. (2021). Effects of different anesthesia methods on maternal and neonatal outcomes in pregnant patients with pulmonary arterial hypertension: a meta-analysis. Archives of Gynecology and Obstetrics. 306(1). 7–15. 3 indexed citations
11.
Wu, Zhilin, et al.. (2021). Association Between Insomnia and Migraine Risk: A Case–Control and Bidirectional Mendelian Randomization Study. Pharmacogenomics and Personalized Medicine. Volume 14. 971–976. 16 indexed citations
12.
Liu, Zhen, Zhouyang Wu, Hongyu Zhao, & Mingzhang Zuo. (2020). Personal protective equipment during tracheal intubation in patients with COVID-19 in China: a cross-sectional survey. British Journal of Anaesthesia. 125(5). e420–e422. 7 indexed citations
13.
Wang, Xin, et al.. (2020). Targeted Antagonism of Vascular Endothelial Growth Factor Reduces Mortality of Mice with Acute Respiratory Distress Syndrome. Current Medical Science. 40(4). 671–676. 4 indexed citations
14.
Xia, Haifa, Yangyang Ge, Fuquan Wang, et al.. (2020). Protectin DX ameliorates inflammation in sepsis-induced acute lung injury through mediating PPARγ/NF-κB pathway. Immunologic Research. 68(5). 280–288. 22 indexed citations
15.
Wu, Zhouyang, et al.. (2018). Vascular endothelial growth factor increased the permeability of respiratory barrier in acute respiratory distress syndrome model in mice. Biomedicine & Pharmacotherapy. 109. 2434–2440. 8 indexed citations
16.
Wu, Zhilin, et al.. (2015). Comparison of cardiac output and hemodynamic responses of intubation among different videolaryngoscopies in normotensive and hypertensive patients. Journal of Huazhong University of Science and Technology [Medical Sciences]. 35(3). 432–438. 9 indexed citations
17.
Li, Hongbin, Guangzhi Wang, Jie Gong, et al.. (2013). BML-111 attenuates hemorrhagic shock-induced acute lung injury through inhibiting activation of mitogen-activated protein kinase pathway in rats. Journal of Surgical Research. 183(2). 710–719. 24 indexed citations
18.
Li, Hongbin, Zhouyang Wu, Dan Feng, et al.. (2013). BML-111, a Lipoxin Receptor Agonist, Attenuates Ventilator-Induced Lung Injury in Rats. Shock. 41(4). 311–316. 24 indexed citations
20.
Shang, You, et al.. (2009). Melatonin reduces acute lung injury in endotoxemic rats.. PubMed. 122(12). 1388–93. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026